Amarantus Bioscience Holdings Inc. announced the appointment of Donald D. Huffman to the company's Board of Directors, where he will chair the newly-formed audit committee. Mr. Huffman brings over 20 years of biopharmaceutical industry experience in various financial and audit roles, with specific expertise in mergers and acquisitions. Mr. Huffman currently serves as a Director of Dance Biopharm Inc. Previously, Mr. Huffman served as the Chief Financial Officer of Wafergen Biosystems Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 630 | |
+46.03% | 56.61B | |
-7.53% | 39.62B | |
+36.02% | 39.25B | |
-9.38% | 28.28B | |
+12.31% | 26.44B | |
-16.38% | 20.12B | |
+30.79% | 12.51B | |
+28.57% | 12.48B | |
-0.36% | 12.2B |
- Stock Market
- Equities
- AMBS Stock
- News Amarantus BioScience Holdings, Inc.
- Amarantus Bioscience Holdings, Inc Appoints Donald D. Huffman to the Board of Directors to Chair the Newly-Formed Audit Committee